相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
Mark J. Kiel et al.
BLOOD (2014)
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
Javeed Iqbal et al.
BLOOD (2014)
STAT3-mediated activation of microRNA cluster 17∼92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma
Elisa Spaccarotella et al.
HAEMATOLOGICA (2014)
Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma
Meenakshi Mehrotra et al.
HUMAN PATHOLOGY (2014)
miR-155 Activates Cytokine Gene Expression in Th17 Cells by Regulating the DNA-Binding Protein Jarid2 to Relieve Polycomb-Mediated Repression
Thelma M. Escobar et al.
IMMUNITY (2014)
Therapeutic opportunities of the IL-22-IL-22R1 system
Robert Sabat et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Reliable Quantification of Protein Expression and Cellular Localization in Histological Sections
Michaela Schlederer et al.
PLOS ONE (2014)
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma
Michela Boi et al.
BLOOD (2013)
Lead identification of novel and selective TYK2 inhibitors
Jun Liang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
A Restricted Role for TYK2 Catalytic Activity in Human Cytokine Responses Revealed by Novel TYK2-Selective Inhibitors
Sue J. Sohn et al.
JOURNAL OF IMMUNOLOGY (2013)
Genome-wide identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IP
Jan Meier et al.
RNA BIOLOGY (2013)
TYK2-STAT1-BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia
Takaomi Sanda et al.
CANCER DISCOVERY (2013)
Extensive Promoter DNA Hypermethylation and Hypomethylation Is Associated with Aberrant MicroRNA Expression in Chronic Lymphocytic Leukemia
Constance Baer et al.
CANCER RESEARCH (2012)
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas
Daniela Laimer et al.
NATURE MEDICINE (2012)
A Genomic Regulatory Element That Directs Assembly and Function of Immune-Specific AP-1-IRF Complexes
Elke Glasmacher et al.
SCIENCE (2012)
Essential Role of MicroRNA-155 in the Pathogenesis of Autoimmune Arthritis in Mice
Stephan Blueml et al.
ARTHRITIS AND RHEUMATISM (2011)
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing
Andrew L. Feldman et al.
BLOOD (2011)
Anaplastic large-cell lymphoma
Giorgio Inghirami et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2011)
Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma
Olaf Merkel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Physiological and pathological roles for microRNAs in the immune system
Ryan M. O'Connell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
IL-21 Contributes to JAK3/STAT3 Activation and Promotes Cell Growth in ALK-Positive Anaplastic Large Cell Lymphoma
Jennifer Dien Bard et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
NPM-ALK inhibits the p53 tumor suppressor pathway in an MDM2 and JNK-dependent manner
Yu-Xin Cui et al.
BLOOD (2009)
B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma
Ryo Yamamoto et al.
CANCER SCIENCE (2009)
Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma
S. Eckerle et al.
LEUKEMIA (2009)
ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified:: report from the International Peripheral T-Cell Lymphoma Project
Kerry J. Savage et al.
BLOOD (2008)
Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder
Ryan M. O'Connell et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma
J. Dien Bard et al.
LEUKEMIA (2008)
The anaplastic lymphoma kinase in the pathogenesis of cancer
Roberto Chiarle et al.
NATURE REVIEWS CANCER (2008)
Regulation of the germinal center response by microRNA-155
To-Ha Thai et al.
SCIENCE (2007)
The NPM-ALK tyrosine kinase mimics TCR signalling pathways, inducing NFAT and AP-1 by RAS-dependent mechanisms
Suzanne D. Turner et al.
CELLULAR SIGNALLING (2007)
Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes
Laurence Lamant et al.
BLOOD (2007)
Functional validation of the analplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes
Roberto Piva et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma
Yajun Han et al.
BLOOD (2006)
Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma
Francisco Vega et al.
CANCER RESEARCH (2006)
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice
S Costinean et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase
C Ambrogio et al.
BLOOD (2005)
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
R Chiarle et al.
NATURE MEDICINE (2005)
Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase
SD Turner et al.
ONCOGENE (2003)
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas, and plasma cell tumors
R Chiarle et al.
BLOOD (2003)
Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice
K Lange et al.
ONCOGENE (2003)
分享论文
